A carregar...
Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective
The incidence rate of breast cancers in People’s Republic of China has increased in the last decade, and many cases are responsive to hormone therapies. The third-generation aromatase inhibitor letrozole inhibits estrogen production, and is more efficacious than the estrogen receptor inhibitor tamox...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780194/ https://ncbi.nlm.nih.gov/pubmed/27042100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S81087 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|